Trending...
- California: Governor Newsom announces appointments 10.31.2025
- Warrior Foundation Freedom Station Starts Give-A-Thon to Fly Our Warriors "Home for the Holidays!"
- For Election Day: Treat yourself to a funny poem and a song about politics called "Run For Office"
Expert declares mental health and psychiatry are in a tailspin. CCHR warns of psychiatric treatment risks, rising drug deaths, and poor psychiatric hospital outcomes requiring close scrutiny.
LOS ANGELES - Californer -- Citizens Commission on Human Rights International, a leading mental health industry watchdog, is calling for a federal audit of the $280 billion spent annually on mental health services, citing decades of failed outcomes and lack of meaningful improvements. Additionally, as CCHR has been exposing since the 1990s, millions of dollars have been wasted on National Institute of Mental Health (NIMH)-funded behavioral and psychiatric research that has included studying whiptail lizards, insects, electric fish and $3.1 million spent on the "vocal learning" of birds. Despite this massive investment, mental health in the U.S. continues to decline. CCHR warns that billions are being squandered on treatment-caused harm, overlooked polypharmacy risks, and rising deaths linked to psychotropic drugs.
President of CCHR, Jan Eastgate, said, "One thing we cannot be thankful for this year is an improved mental health system. We must acknowledge the financial costs and the toll on patients' health caused by extremely poor therapy outcomes, lack of cures, and rising deaths. The industry is plagued by iatrogenesis—the phenomenon of the 'healer' causing harm."
According to TIME magazine, "The U.S. has reached peak therapy. Counseling has become fodder for hit books, podcasts, and movies. Professional athletes, celebrities, and politicians routinely go public with their mental health struggles…. But something isn't adding up. Even as more people flock to therapy, U.S. mental health is getting worse by multiple metrics. Suicide rates have risen by about 30% since 2000."[1]
More on The Californer
Polypharmacy, the practice of prescribing multiple psychotropic drugs simultaneously, is alarmingly common. This approach often leads to harmful drug interactions. Among the most overprescribed drugs and dangerous drugs are benzodiazepines, commonly referred to as "benzos." From mid-February to mid-March of 2020, prescriptions for these increased by 34%. Within a few short weeks, patients can develop a physical dependence on them ending up worse off than before the medications, struggling with addiction and withdrawal. Benzos can also have serious side effects, including respiratory depression, which can cause death. Stanford psychiatrist Anna Lembke, lead author of a New England Journal of Medicine essay, calls our overprescribing and overuse of benzos a "hidden epidemic."[2]
Over 21 years (1999-2019), 51,446 psychotropic-drug-implicated deaths (where psychotropic drugs were a contributing cause of death) occurred, with the annual psychotropic-drug-implicated death rate increasing over 3.4 times from 0.40 to 1.37 per 100,000. During the same period, there were also 649,697 psychotropic drug overdoses.[3]
In psychiatry, iatrogenesis has traditionally been linked to complications of psychotropic drug treatment, Medical Xpress reports. "Current classification systems in psychiatry fail to consider the iatrogenic components of psychopathology related to behavioral toxicity [the negative effects of therapeutic levels of medication]." These drugs' "paradoxical effects, manifestations of tolerance (loss of clinical effect, refractoriness), withdrawal and post-withdrawal disorders, are increasingly common due to the widespread use of psychotropic drugs in the general population."[4] In other words, psychiatry often ignores the harmful side effects caused by psychiatric drugs, such as worsening mental health and withdrawal symptoms, which are becoming more common as these drugs are widely used.
There are at least 180 psychiatric drugs on the market, not including all generic versions. Some of the iatrogenic effects include irreversible movement disorders causing uncontrollable muscle contractions such as tardive dyskinesia (TD), akathisia and dystonia. TD occurs in 20%-50% of patients taking antipsychotics and is also linked to antidepressants, mood stabilizers and stimulants.[5]
More on The Californer
Some psychotropics are nearly six times more likely to drive the person taking them to suicide than those not taking them, while spending time in a psychiatric hospital can increase that risk of self-inflicted death by 44 times.[6]
Clinical Psychology Science and Practice reported there is considerable evidence of heightened suicide risk and other negative outcomes during and immediately following hospitalization. As such, psychiatric hospitalization is iatrogenic. Despite limited research demonstrating its effectiveness in reducing suicide risk, inpatient hospitalization remains a primary "treatment" (often legally mandated, or forced) for individuals with high risk of suicide.[7]
Stanton Peele, Ph.D., states that "The world of mental health and psychiatry is in a tailspin," and cites Insel's "own confessional professional memoir," admitting, "The U.S., a country that leads the world in spending on medical research, also stands out for its dismal outcomes in people with mental illnesses. Indeed, over the last three decades, even as the government invested billions of dollars in better understanding the brain, by some measures, those outcomes have deteriorated."[8]
Founded in 1969 by the Church of Scientology and renowned University of New York psychiatrist Prof. Thomas Szasz, CCHR is calling for a transparent audit of the funds allocated to psychiatric services and their outcomes, and mental health research under NIMH. This audit aims to identify the failed treatments and programs that have contributed to the worsening state of the nation's mental health system.
Sources:
[1] time.com/6308096/therapy-mental-health-worse-us/
[2] time.com/6280929/polypharmacy-dangers-essay/
[3] pmc.ncbi.nlm.nih.gov/articles/PMC8355085/
[4] medicalxpress.com/news/2019-07-iatrogenic-disorders-psychiatry-common-neglected.html
[5] www.ncbi.nlm.nih.gov/pmc/articles/PMC5472076/
[6] link.springer.com/article/10.1007/s00127-014-0912-2
[7] www.researchgate.net/publication/339741738_The_potential_iatrogenic_effects_of_psychiatric_hospitalization_for_suicidal_behavior_A_critical_review_and_recommendations_for_research
[8] peele.net/lib/americanpsychiatry.html
President of CCHR, Jan Eastgate, said, "One thing we cannot be thankful for this year is an improved mental health system. We must acknowledge the financial costs and the toll on patients' health caused by extremely poor therapy outcomes, lack of cures, and rising deaths. The industry is plagued by iatrogenesis—the phenomenon of the 'healer' causing harm."
According to TIME magazine, "The U.S. has reached peak therapy. Counseling has become fodder for hit books, podcasts, and movies. Professional athletes, celebrities, and politicians routinely go public with their mental health struggles…. But something isn't adding up. Even as more people flock to therapy, U.S. mental health is getting worse by multiple metrics. Suicide rates have risen by about 30% since 2000."[1]
More on The Californer
- Jonathan Malveaux Named Newest Member of Forbes Business Council
- The Hangover: Post November 4th Blues
- Divine Logic Launches Proactive Managed IT Services for Fresno Businesses
- NFL Midseason 2025: Who's for Real and Who's Faking It?
- Silver Ball, Golden Heart: Dallas-Area Pinball Wizards Flip for Charity at Side Quest Arcade
Polypharmacy, the practice of prescribing multiple psychotropic drugs simultaneously, is alarmingly common. This approach often leads to harmful drug interactions. Among the most overprescribed drugs and dangerous drugs are benzodiazepines, commonly referred to as "benzos." From mid-February to mid-March of 2020, prescriptions for these increased by 34%. Within a few short weeks, patients can develop a physical dependence on them ending up worse off than before the medications, struggling with addiction and withdrawal. Benzos can also have serious side effects, including respiratory depression, which can cause death. Stanford psychiatrist Anna Lembke, lead author of a New England Journal of Medicine essay, calls our overprescribing and overuse of benzos a "hidden epidemic."[2]
Over 21 years (1999-2019), 51,446 psychotropic-drug-implicated deaths (where psychotropic drugs were a contributing cause of death) occurred, with the annual psychotropic-drug-implicated death rate increasing over 3.4 times from 0.40 to 1.37 per 100,000. During the same period, there were also 649,697 psychotropic drug overdoses.[3]
In psychiatry, iatrogenesis has traditionally been linked to complications of psychotropic drug treatment, Medical Xpress reports. "Current classification systems in psychiatry fail to consider the iatrogenic components of psychopathology related to behavioral toxicity [the negative effects of therapeutic levels of medication]." These drugs' "paradoxical effects, manifestations of tolerance (loss of clinical effect, refractoriness), withdrawal and post-withdrawal disorders, are increasingly common due to the widespread use of psychotropic drugs in the general population."[4] In other words, psychiatry often ignores the harmful side effects caused by psychiatric drugs, such as worsening mental health and withdrawal symptoms, which are becoming more common as these drugs are widely used.
There are at least 180 psychiatric drugs on the market, not including all generic versions. Some of the iatrogenic effects include irreversible movement disorders causing uncontrollable muscle contractions such as tardive dyskinesia (TD), akathisia and dystonia. TD occurs in 20%-50% of patients taking antipsychotics and is also linked to antidepressants, mood stabilizers and stimulants.[5]
More on The Californer
- Sweet Beginnings: Sugar Queen Dessert Shop Opens in the Colony Ridge Community
- World Record Established: Million-Dollar Bilibin Screen Sells at Shapiro Auctions
- SEEAG's "Christmas On The Ranch" Offers Fresh-Cut Christmas Trees From Northern California
- PJHM Architects Honored with Outstanding Project Award for Patrick Henry High School Design
- Gold Standard Diagnostics Launches AIX1000 2.1® with Extra High Titer RPR Testing
Some psychotropics are nearly six times more likely to drive the person taking them to suicide than those not taking them, while spending time in a psychiatric hospital can increase that risk of self-inflicted death by 44 times.[6]
Clinical Psychology Science and Practice reported there is considerable evidence of heightened suicide risk and other negative outcomes during and immediately following hospitalization. As such, psychiatric hospitalization is iatrogenic. Despite limited research demonstrating its effectiveness in reducing suicide risk, inpatient hospitalization remains a primary "treatment" (often legally mandated, or forced) for individuals with high risk of suicide.[7]
Stanton Peele, Ph.D., states that "The world of mental health and psychiatry is in a tailspin," and cites Insel's "own confessional professional memoir," admitting, "The U.S., a country that leads the world in spending on medical research, also stands out for its dismal outcomes in people with mental illnesses. Indeed, over the last three decades, even as the government invested billions of dollars in better understanding the brain, by some measures, those outcomes have deteriorated."[8]
Founded in 1969 by the Church of Scientology and renowned University of New York psychiatrist Prof. Thomas Szasz, CCHR is calling for a transparent audit of the funds allocated to psychiatric services and their outcomes, and mental health research under NIMH. This audit aims to identify the failed treatments and programs that have contributed to the worsening state of the nation's mental health system.
Sources:
[1] time.com/6308096/therapy-mental-health-worse-us/
[2] time.com/6280929/polypharmacy-dangers-essay/
[3] pmc.ncbi.nlm.nih.gov/articles/PMC8355085/
[4] medicalxpress.com/news/2019-07-iatrogenic-disorders-psychiatry-common-neglected.html
[5] www.ncbi.nlm.nih.gov/pmc/articles/PMC5472076/
[6] link.springer.com/article/10.1007/s00127-014-0912-2
[7] www.researchgate.net/publication/339741738_The_potential_iatrogenic_effects_of_psychiatric_hospitalization_for_suicidal_behavior_A_critical_review_and_recommendations_for_research
[8] peele.net/lib/americanpsychiatry.html
Source: Citizens Commission on Human Rights
Filed Under: Consumer, Medical, Health, Government, Legal, Citizens Commission On Human Rights, CCHR International, Jan Eastgate
0 Comments
Latest on The Californer
- American Star Guard Unveils a Powerful Rebrand and Expanded Security Services Throughout Nevada
- Health Reform 2025 Calls for the Creation of a U.S. Department of Wellness
- PlaceBased Media Expands Point-of-Care Advertising Inventory Across U.S. Clinic Network
- Flexible Plan Investments launches FlexDirex, a first-to-market suite of single-stock ETF strategies in the U.S
- Scatil Investment Alliance Under Damian Mercer Modernizes Core Systems
- City of Long Beach Reaches Tentative Labor Agreement with Long Beach Firefighters Association
- Have Breakfast with Santa And Shop For Christmas Trees At Simi Valley Family YMCA
- Divine Logic Launches New Website to Help Fresno Businesses Simplify IT and Compliance
- City of Long Beach and Long Beach Lifeguards Association Reach Tentative Labor Agreement
- Historic 1947 Trumpy Yacht Mauretania Featured in Wooden Boat Magazine
- California Music Hall of Fame 2025 Induction Ceremony at Warner Bros. Studios November 15th
- Angel Light Academy Honors 8 Community Members Who Demonstrate Excellence in Leadership and Service 18th Annual Above & Beyond Awards November 8
- Culture, Classical Guitar and Comedy... HealthyLife.net Radio adds new programs
- THINKWARE to Showcase Three Next-Generation Dash Cams at SEMA Show
- ICYMI: Coreshell Technologies wins $1 million grand prize at Startup World Cup Grand Finale, highlighting California's entrepreneurial leadership
- Small-Firm Leaders Must Prioritize High-Impact Tasks to Prevent Burnout: New Article in AT
- Stockdale Capital Partners Acquires 266-Unit Class-A Scottsdale, AZ Multifamily Community
- Revenue Optics Ignites AI Revolution in Industrial Distribution
- Arnica Unveils "Arnie AI" to Secure the Future of AI-Driven Software Development
- Axiros North America Announces New CEO: Gabriel Davidov
